Mr. Jonker joins Theravance from Satori Pharmaceuticals, where he served as Chief Business Officer. Previously, he held senior business development and corporate strategy positions with Gloucester Pharmaceuticals and Genentech, Inc. Prior to Genentech, Mr. Jonker was an attorney in the Technology Transactions Group of Wilson, Sonsini, Goodrich & Rosati, representing clients in biotech, life sciences and high tech industries. Mr. Jonker holds a J.D. from Columbia University School of Law, an M.LITT. from the University of St. Andrews and a B.A. from Claremont McKenna College. "We are very excited to have Jeff join the executive team at Theravance," said Rick E Winningham, Chief Executive Officer. "Jeff brings a wealth of industry and deal experience to Theravance.